Skip to content
healthcare.dev

KEYTRUDA

NDC 0006-3026, pembrolizumab, injection, solution, from Merck Sharp & Dohme LLC.

Product NDC
0006-3026
Status
Listed
Labeler
Merck Sharp & Dohme LLC
Dosage form
INJECTION, SOLUTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
BLA
Application
BLA125514
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0006-3026 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • PEMBROLIZUMAB25 mg/mL

Pharmacologic classes

Programmed Death Receptor-1 Blocking Antibody [EPC]; Programmed Death Receptor-1-directed Antibody Interactions [MoA]

Package NDCNDC-11Package
0006-3026-02000063026021 VIAL in 1 CARTON (0006-3026-02) / 4 mL in 1 VIAL (0006-3026-01)
0006-3026-04000063026042 VIAL in 1 CARTON (0006-3026-04) / 4 mL in 1 VIAL (0006-3026-01)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/9333c79b-d487-4538-a9f0-71b91a02b287
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=0006-3026

Use it

Look up 0006-3026 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0006-3026 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0006-3026. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.